News releases

ALL

Feb 25, 2026 other

other

Notice Regarding Request to Provide Additional Information on Large-Scale Purchases of Share Certificates, Etc.(329 KB)
Feb 12, 2026 other

other

Responding to Shareholders’ Request for a Lawsuit (Non-Prosecution)(147 KB)
Feb 12, 2026 other

other

Our Understanding of Matters Stated in 3D Investment Partners Pte. Ltd.’s Explanatory Statement on Large-Scale Purchase Actions, Etc., and Response Letter(156 KB)
Feb 12, 2026 performance

performance

Consolidated Financial Results for the Nine Months Ended December 31, 2025(303 KB)
Feb 12, 2026 stock

stock

Notice Regarding the Revision of Dividend Forecasts for the Fiscal Year Ending March 2026(82 KB)
Feb 03, 2026 other

other

Notice on Receipt of Response to Request to Provide Information on Large-Scale Purchases of Share Certificates, Etc.(109 KB)
Jan 27, 2026 M&A/partnership

M&A/partnership

Conclusion of Capital and Business Alliance with Surv BioPharma Inc.(229 KB)
Jan 23, 2026 other

other

Notice on Request to Provide Information on Large-Scale Purchases of Share Certificates, Etc.(214 KB)
Jan 16, 2026 other

other

Notice of Receipt of a Large-Scale Purchase Explanation Related to Large-Scale Purchases of Share Certificates, Etc.(116 KB)
Dec 26, 2025 other

other

Notice Regarding Receipt of Letter from 3D Investment Partners Pte. Ltd. Concerning Establishment of Third-Party Committee and Submission of Response Letter(209 KB)
Dec 19, 2025 stock

stock

Notice of the Posting of a Gain on Sale of Investment Securities (Extraordinary Income)(118 KB)
Dec 05, 2025 product/service

product/service

Notice Regarding Launch of KYOSOMIRAI PHARMA of 1 Ingredient / 3 Products of Generic Drugs(216 KB)
Nov 19, 2025 stock

stock

Notice Concerning the Results of Share Buybacks and Completion of Acquisition(115 KB)
Nov 12, 2025 performance

performance

Consolidated Financial Results for the Six Months Ended September 30, 2025(458 KB)